BE832888A - Steroides de la serie de l'androstane et leur obtention - Google Patents

Steroides de la serie de l'androstane et leur obtention

Info

Publication number
BE832888A
BE832888A BE159586A BE159582A BE832888A BE 832888 A BE832888 A BE 832888A BE 159586 A BE159586 A BE 159586A BE 159582 A BE159582 A BE 159582A BE 832888 A BE832888 A BE 832888A
Authority
BE
Belgium
Prior art keywords
obtaining
androstane series
steroids
series steroids
androstane
Prior art date
Application number
BE159586A
Other languages
English (en)
French (fr)
Inventor
Gordon Hanley Phillipps
Brian Mcdonald Bain
John Colin Clark
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of BE832888A publication Critical patent/BE832888A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
BE159586A 1974-08-30 1975-08-29 Steroides de la serie de l'androstane et leur obtention BE832888A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB38089/74A GB1517278A (en) 1974-08-30 1974-08-30 Alkyl and haloalkyl androsta-1,4,15-triene and-4,15-diene-17beta-carboxylates

Publications (1)

Publication Number Publication Date
BE832888A true BE832888A (fr) 1976-03-01

Family

ID=10401103

Family Applications (1)

Application Number Title Priority Date Filing Date
BE159586A BE832888A (fr) 1974-08-30 1975-08-29 Steroides de la serie de l'androstane et leur obtention

Country Status (12)

Country Link
US (1) US3981894A (it)
JP (1) JPS5148648A (it)
BE (1) BE832888A (it)
CH (1) CH612687A5 (it)
DE (1) DE2538627A1 (it)
DK (1) DK136075B (it)
FR (1) FR2282898A1 (it)
GB (1) GB1517278A (it)
IE (1) IE41662B1 (it)
NL (1) NL7510225A (it)
SE (1) SE411904B (it)
ZA (1) ZA755554B (it)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3002746A1 (de) * 1980-01-23 1981-07-30 Schering Ag Berlin Und Bergkamen, 1000 Berlin 1-hydroxysteroide, verfahren zu ihrer herstellung und pharmazeutische praeparate, die diese verbindungen enthalten
SE8501693D0 (sv) * 1985-04-04 1985-04-04 Draco Ab Novel 16,17-acetalsubstituted androstane-17beta-carboxylic acid esters
IL78144A0 (en) * 1985-04-04 1986-07-31 Draco Ab Novel androstane-17beta-carboxylic acid esters
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
DK1775305T3 (en) 2000-08-05 2014-11-17 Glaxo Group Ltd 6.Alfa.,9.alfa.-difluoro-17.alfa.-'(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alfa.-methyl-3-oxo-androst-1,4,-diene-17-carbothiotic acid s-fluoromethyl ester as an anti-inflammatory agent
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6777400B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6787532B2 (en) 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
EP2039700A2 (en) * 2001-04-30 2009-03-25 Glaxo Group Limited Novel anti-inflammatory androstane derivatives
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3828080A (en) * 1972-01-20 1974-08-06 Glaxo Lab Ltd Androstane-17beta-carboxylic acids and processes for the preparation thereof

Also Published As

Publication number Publication date
ZA755554B (en) 1976-08-25
DK136075C (it) 1978-01-09
IE41662B1 (en) 1980-02-27
IE41662L (en) 1976-02-29
DK389375A (it) 1976-03-01
DK136075B (da) 1977-08-08
FR2282898A1 (fr) 1976-03-26
SE7509650L (sv) 1976-03-01
CH612687A5 (it) 1979-08-15
US3981894A (en) 1976-09-21
SE411904B (sv) 1980-02-11
GB1517278A (en) 1978-07-12
AU8440375A (en) 1977-03-03
DE2538627A1 (de) 1976-03-11
NL7510225A (nl) 1976-03-02
FR2282898B1 (it) 1978-11-10
JPS5148648A (it) 1976-04-26

Similar Documents

Publication Publication Date Title
BE832888A (fr) Steroides de la serie de l'androstane et leur obtention
BE836813A (fr) Composes thiazolyacetamido et leur preparation
BE852857A (fr) Compositions cimentaires et leur production
BE833044A (fr) 4-arylpiperidines 1, 3, 4 -trisubtituees et leur preparation
BE832889A (fr) Steroides de la serie de l'androstane et leur preparation
BE832860A (fr) Benzo-isoquinoleine-diones et leur preparation
BE833586A (fr) Aminobenzazocines et leur preparation
FR2285891A1 (fr) Nouvelles benzodiazepines et leur preparation
FR2277808A1 (fr) Phenoxybenzenes substitues et leur preparation
FR2291978A1 (fr) Derives de 2-phenyl-1,2,3-triazolofluorane, leur preparation et leur utilisation
BE825982A (fr) Triazoloquinazolines et leur preparation
FR2286176A1 (fr) Pigments bis-azoiques et leur preparation
NZ185341A (en) 19-oxygenated steroids and pharmaceutical compositions
NZ185296A (en) Corticoids and pharmaceutical compositions
BE830239A (fr) Compositions de steroides stabilisees et leur preparation
BE828447A (fr) Nouveaux steroides substitues en position 11 de la serie de l'oestrane
BE855224A (fr) Analogues de 5,6-dihydro-prostacycline et leur preparation
BE829987R (fr) Pyrimidines condensees et leur preparation
BE826925A (fr) Nouvelles pyrrolodiazepines et leur preparation
BE835912A (fr) (16alpha,17-beta)-naphtalenes steroidiques et leur preparation
BE832464A (fr) 3,4-dihydro-2h-isoquinoleine-1-thiones et leur preparation
BE829153A (fr) 5-phenyl-thiazolidine-4-ones et leur preparation
BE826986A (fr) Nouvelles benzodiazepines et leur preparation
FR2316959A1 (fr) 21-acetals et acetals mixtes de steroides de la serie des corticoides
BE831931A (fr) Nouveaux 17alpha, 21-diesters de 17alpha,21-dihydroxy steroides et leur preparation